IRIS

The influence of alprazolam on the monoaminergic neurotransmitter systems in dysthymic patients. Relationship to clinical response

SANTAGOSTINO BARBONE, GIUSEPPE;CUCCHI, MARIA LAURA;FRATTINI, PIETRO;PREDA, STEFANIA;CORONA, GIAN LUIGI
1998-01-01
1998
Pharmacology & Toxicology includes all aspects of pharmacology, toxicology, and pharmaceutics. Of particular importance are cellular and molecular pharmacology, drug design and metabolism, mechanisms of drug action, drug delivery, natural products, xenobiotics, and clinical therapeutics. Toxicology coverage considers cellular and molecular effects of harmful substances, environmental toxicology, occupational exposure, and clinical toxicology. Drug bulletins, drug updates, and pharmaceutical newsletters are excluded as are resources on pharmaceutical engineering. Medicinal chemistry, or synthesis and chemical analysis of pharmaceuticals are placed in the Chemistry & Analysis category.
PHARMACOPSYCHIATRY
sì
2-s2.0-0031780144
Sì, ma tipo non specificato
Inglese
Internazionale
STAMPA
31
1
6
Neurotransmitter metabolites; Dysthymia; Alprazolam
7
info:eu-repo/semantics/article
262
SANTAGOSTINO BARBONE, Giuseppe; Cucchi, MARIA LAURA; Frattini, Pietro; F., Zerbi; E., DI PAOLO; Preda, Stefania; Corona, GIAN LUIGI
1 Contributo su Rivista::1.1 Articolo in rivista
none
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/112466
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 5
  • ???jsp.display-item.citation.isi??? ND
social impact